
Private practice rheumatologists, including Saimun Singla, DO, FACR, will explain how they successfully implemented the direct care model and how it has affected their job satisfaction and patient care.
Osteoarthritis (OA) researcher Richard F. Loeser, Jr., MD, MACR, will explain the fundamental science underlying OA pathogenesis and the potential therapeutic interventions for the disease.
A Sunday morning session will delve into the dynamics of how microbial and host byproducts drive inflammation. One of the featured speakers, Renuka Nayak, MD, PhD, will discuss therapeutic approaches to treat rheumatoid arthritis using short-chain fatty acids.
Experts, including Kim M. Huffman, MD, PhD, will highlight how this approach to physical activity affects cardiovascular health, physical function, and immune response.
Speakers, including Diana Girnita, MD, PhD, will share what they have learned about making a private rheumatology practice stand out from the crowd and building trust among patients and prospective patients.
Jennifer Strouse, MD, FACR, and Juliet Aizer, MD, MPH, both experienced instructors, will discuss the impact of generational change on the rheumatology fellowship training environment and strategies to meet the needs of modern learners.
Sabine Grimm, PhD, MSc, examined how this multidisciplinary process can be harnessed to the benefit of decision-makers, guideline developers, payers, and patients.
On Sunday, speakers will explain how to choose the appropriate statistical analysis for the research question at hand. On Monday, presenters will introduce latent structures and latent variable models.
Panelists, including Joan Merrill, MD, will discuss data from preliminary studies of chimeric antigen receptor (CAR) T-cell therapy treatment for lupus and review potential future therapies, including autologous CAR-T cells targeting alternative antigens, allogeneic cell therapy treatments, and strategic cell-harnessing treatments.
Eliza Pei-Suen Tsou, PhD, will discuss the role of senescence and the scleroderma vasculature as part of a session on the central role of vasculopathy in systemic sclerosis.